Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

213.53 USD UNCHANGED
Streaming Delayed Price Updated: 4:12 PM EST, Dec 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Systemic Lupus Erythematosus Treatment Market Projected To Reach $3.56 Billion By 2027
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
Image Provided By Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house ... 
Tags Market News HOTH AMGN
From Benzinga
Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022
Can-Fite BioPharma Ltd(NYSE: CANF) announced that the last of approximately 400 psoriasis patients enrolled in its Phase 3 Comfort ... 
Tags AMGN Briefs Psoriasis
From Benzinga
What 8 Analyst Ratings Have To Say About Amgen
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following analyst ratings: Bullish Somewhat ... 
Tags Benzinga Analyst Ratings Market News
From Benzinga
Nasdaq 100 Movers: AMD, BKNG
In early trading on Monday, shares of Booking Holdings topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.5%. Year to date, Booking Holdings has lost about... 
Tags Stocks
From Market News Video
Dow Movers: CRM, AMGN
In early trading on Monday, shares of Amgen topped the list of the day's best performing Dow Jones Industrial Average components, trading up 4.3%. Year to date, Amgen has lost about 8.2% of its value. 
Tags Stocks
From Market News Video
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX:MAG) was changed from Hold to ... 
Tags PNC GRUB BECN
From Benzinga
Time To Load Up? This Dividend Growth Stock Has Been Beat Down By 30%
Amgen is benefiting from a rising tide that is lifting all boats. Already, Amgen has increased its dividend for 11 consecutive years. 
Tags Stocks / Equities Market News Healthcare
From TalkMarkets
3 Must-Own Dividend Stocks in This Chaotic Market
These three pharmaceutical stocks could buffer your portfolio against further market turbulence. 
Tags BMY Market News AMGN
From Motley Fool
A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Up 2%
Pre-open movers U.S. stock futures traded mostly higher in early pre-market trade after the Nasdaq dropped close to 300 points in the ... 
Tags BABA Pre/Market Outlook BXP
From Benzinga
5 Stocks To Watch For December 6, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Science Applications International Corporation (NYSE: ... 
Tags Earnings SAIC NIO
From Benzinga
4 Top Nasdaq-100 Stocks To Buy In December
The tech-heavy Nasdaq 100 trended higher this week amid the uncertainties surrounding inflation and the emergence of the Omicron coronavirus variant. So, we believe these fundamentally sound Nasdaq 100... 
Tags Stocks / Equities Market News
From TalkMarkets
Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LLY, GILD, MRK)
Tags Finance U/S Financial Market
From AB Newswire
Interesting AMGN Put And Call Options For January 2022
Investors in Amgen Inc (AMGN) saw new options become available today, for the January 2022 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMGN options chain for... 
Tags Stocks
From Market News Video
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, ... 
Tags FDA General Penny Stocks
From Benzinga
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks of 2021?
The pullbacks make short-term sense, but may ultimately be long-term mistakes. 
Tags AMGN Market News VZ
From Motley Fool
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy ... 
Tags Biotech Small Cap TMDI
From Benzinga
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
Johnson & Johnson's(NYSE: JNJ) Janssen Biotech Inc hasreceived FDA approvalfor Darzalex Faspro (daratumumab ... 
Tags Market News HALO News
From Benzinga
Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study
Amgen Inc(NASDAQ: AMGN)announced topline resultsfrom the DISCREET trial Phase 3 trial of Otezla (apremilast) in adults ... 
Tags Phase 3 Trial Market News News
From Benzinga
DSI, SCHW, AMGN, AXP: ETF Inflow Alert
Symbols mentioned in this story: DSI, SCHW, AMGN, AXP Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
2 Ridiculously Cheap Dividend Stocks To Buy for 2022
AbbVie and ViacomCBS can provide investors a good mix of growth and dividend income. 
Tags MRK AMGN DIS
From Motley Fool
7 Drug Stocks to Buy Now While They’re Still on Sale
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead. The... 
Tags PG AMGN VTRS
From InvestorPlace
Amgen: For Growth And Income Investors
Amgen focuses on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. 
Tags Market News Stocks / Equities Pharma/Biotech
From TalkMarkets
Price Over Earnings Overview: Amgen
In the current market session, Amgen Inc. (NASDAQ:AMGN) is trading at $202.59, after a 0.75% gain. However, over the ... 
Tags Benzinga AMGN Earnings
From Benzinga
Bristol Myers' Deucravacitinib Under FDA Review For Plaque Psoriasis
TheFDA has accepted for reviewBristol Myers Squibb & Co's(NYSE: BMY) deucravacitinib for the treatment of ... 
Tags FDA General AMGN
From Benzinga
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
Affimed, Amgen, and Bristol Myers Squibb are too cheap to ignore right now. 
Tags XBI NVAX MRNA
From Motley Fool
Should You Buy This Giant Biotech Stock?
Amgen beat analysts' earnings expectations in the third quarter, and its balance sheet remains admirable. 
Tags AMGN Market News Recent Press Releases
From Motley Fool
January 2022 Options Now Available For Amgen (AMGN)
Investors in Amgen Inc (AMGN) saw new options become available today, for the January 2022 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMGN options chain for... 
Tags Stocks
From Market News Video
10 Biggest Price Target Changes For Monday
MKM Partners cut Activision Blizzard, Inc. (NASDAQ: ATVI) price target from $75 to $54. Activision Blizzard shares fell 0.9% to ... 
Tags Analyst Ratings BMRN Small Cap
From Benzinga
1 Cancer Stock on Buyout Watch in 2022
Cardiff Oncology is a prime takeover target heading into 2022. 
Tags AMGN PFE MRNA
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.